Skip to content
Delayed ~15 min

FTRE FORTREA HOLDINGS INC

Health Care · Russell 2000

Next earnings: not announced yet

What 14 analyst firms say about FORTREA HOLDINGS INC: their latest ratings, price targets and how far the stock is from them. How it works

21.96 USD+1.50 (+7.33%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+14.5%to the avg target 25.14 USD+3.18 USD
Buy 9 · Hold 4 · Sell 1

14 rated views · 16 analyst/firm records · 14 firms

Latest report2 Nov 2026avg report date 20 Sep
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8044
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8057

Recent analyst activity · last 90 days

Our tracked history has 15 reports on FTRE from 12 analyst firms in the last 90 days (14 firms in the past year).

Comparing each firm's latest target with its previous one: 5 raised their price target, 1 left it unchanged and 2 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: TD Cowen raised its target from $23.00 (set 4 Aug 2026) to $26.00 on 2 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BairdEric W ColdwellBuy24 Sep 2026Conflicting reports · excluded
BarclaysLuke SergottBuy30 Oct 202626.00 USD
CitigroupAlbert HuBuy30 Oct 202627.00 USD
CitigroupBrendan DiganBuy29 Oct 202627.00 USD
CitigroupPatrick DonnellyBuy31 Jul 202622.00 USD
Deutsche BankJustin BowersBuy15 Oct 202625.00 USD
Evercore ISIElizabeth AndersonBuy30 Oct 202628.00 USD
JefferiesDavid WindleyHold30 Oct 202621.50 USD
MizuhoAnn HynesHold13 Jul 2026Conflicting reports · excluded
TD CowenCharles RhyeeBuy2 Nov 202626.00 USD
TruistJaliendra SinghBuy30 Oct 202629.00 USD
UBSKevin CaliendoHold20 Oct 202624.00 USD
WedbushUnnamed analyst—11 Dec 202521.00 USD
Weiss RatingsUnnamed analyst—15 Oct 2026—
William BlairJared HaaseHold29 Oct 2026—
Data feed RESEARCHResearch TeamSell12 Oct 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 02:56 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.